The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Telmisartan/Hydrochlorothiazide 80 mg/12.5 mg tablets

80 mg / 12.5 milligram(s) Tablet

Accord Healthcare Ireland Ltd.PA2315/015/002

Main Information

Trade NameTelmisartan/Hydrochlorothiazide 80 mg/12.5 mg tablets
Active SubstancesTelmisartan
Strength80 mg / 12.5 milligram(s)
Dosage FormTablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/015/002

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA07 telmisartan and diuretics


Licence Issued02/08/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0050-081-039
Interchangeable List DocumentPDF of Interchangeable List
« Back